This brand name is authorized in Austria, South Africa
The drug PENTHROP contains one active pharmaceutical ingredient (API):
1
Methoxyflurane
UNII 30905R8O7B - METHOXYFLURANE
|
Methoxyflurane belongs to the fluorinated hydrocarbon group of volatile anaesthetic agents and provides analgesia when inhaled at low concentrations in conscious patients. Methoxyflurane induces muscle relaxation and reduces pains sensitivity by altering tissue excitability by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PENTHROP Inhalation solution | Health Products Regulatory Authority (ZA) | MPI, Generic |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02BG09 | Methoxyflurane | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BG Other analgesics and antipyretics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: ZA | Health Products Regulatory Authority | Identifier(s): 45/2.9/1118 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.